Clonazepam Tablet
Product Images NDC 70518-2334

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 70518-2334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Clonazepam 1 mg tablet packaging label showing the proprietary name clonaePAM, quantity of 100 tablets, classified as a C-IV controlled substance. The label includes the NDC 70518-2334-00, manufacturer information (Accord, Durham, NC), and repackaging information by RemedyRepack Inc. Directions and cautions advise consulting the package insert and federal law restrictions on drug transfer.*

FDA Label Image

Mm2 (Clonazepam 1mg 70518 2334 01)

Packaging label for Clonazepam 1 mg oral tablet, repackaged by RemedyRepack Inc. The label includes quantity of 1 tablet and classification as C-IV controlled substance. It also notes the original manufacturer as Accord, Durham, NC, and states this is a prescription only drug.*

FDA Label Image

Clonazepam Structural Formula (Fig 1)

Chemical structure of clonazepam showing its bicyclic benzodiazepine core with a nitro group and a chlorophenyl substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.